|
|
|
|
|
|
|
|
|
|
Endocyte jumps on plans for cancer drug candidate - Bioscience Technology:
 The Inquisitr |
Endocyte jumps on plans for cancer drug candidate
Bioscience Technology The study is designed to compare EC145 to the chemotherapy drug Doxil as a treatment for ovarian cancer. Enrollment stopped because of a shortage of Doxil, and the company said Tuesday that the Food and Drug Administration will allow it to import the ... Endocyte Prepares To Restart Clinical Trials For Experimental Cancer DrugThe Inquisitr Endocyte to seek European OK for ovarian cancer drugIndianapolis Star Endocyte to Submit EU Conditional Marketing Authorization Applications for ...MarketWatch (press release) Wall Street Journal -Indianapolis Business Journal all 21 news articles » |
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.